Table 1. Demographic, Laboratory, Ultrasound, and Histological Features of the First Group of Patients (n = 249) .
| Items | Data |
|---|---|
| Age, y, No. (Median) | 48 (35-54.5) |
| Sex | |
| Male, % | 61.8 |
| Female, % | 38.2 |
| Alcohol consumption, % | 12 |
| Pervious Antiviral treatment, % | 13.2 |
| Splenomegaly at ultrasound, % | 23 |
| Iron, μg/mL, No. (Median) | 118 (85.5-148.5) |
| Glucose, mg/dL, No. (Median) | 90 (80.25-101) |
| Total Bilirubin, mg/dL, No. (Median) | 0.66 (0.50-0.87) |
| ASTa, U/L, No. (Median) | 62 (40.5-93) |
| ALTa, U/L, No. (Median) | 106 (59-176) |
| Alkaline phosphatase,U/L, No. (Median) | 149 (103.5-208) |
| Albumin, g/dL, No. (Median) | 4.4 (4.2-4.6) |
| Cholinesterase,U/L, No. (Median) | 10,754 (8,334-12613) |
| White blood cells,cells/ μL, No. (Median) | 6,400 (5,370-7700) |
| Red blood cells,cells/ μL, No. (Median) | 4,870,000 (4,625,000-5,190,000) |
| Platelets, elements/μL, No. (Median) | 193,000 (159,000-234,000) |
| Hemoglobin,g/dL, No. (Median) | 15.1 (14.2-15.9) |
| Prothrombin activity, % | 99 (90-107) |
| Alpha-fetoprotein,pg/mL, No. (Median) | 4 (2.3-8.1) |
| Ferritin,ng/mL, No. (Median) | 162 (80-265.75) |
| HCVaRNA, UI/mL, No. (Median) | 515,000 (200,000 – 850,000) |
| Cirrhosis at liver biopsy, % | 20.5 |
| Staging at liver biopsyb, % | |
| 0 | 1.6 |
| 1 | 34.5 |
| 2 | 21.7 |
| 3 | 12.4 |
| 4 | 9.2 |
| 5 | 7.2 |
| 6 | 13.3 |
aAbbreviations: ALT, Alanine Aminotransferase; AST, Aspartate Aminotransferase; HCV, hepatitis C virus
bAccording to Ishak classification